The US$2 million (A$3.2 million) prize will help to accelerate the use of Vaxxas' high-density microarray patch (HD-MAP) technology to administer mRNA vaccines manufactured at UQ's BASE facility.

Scientists Katalin Kariko and Drew Weissmann have been awarded the 2023 Medicine Nobel Prize for their development of the mRNA technology for the production of Covid-19 vaccines, it was announced ...

Dr. Drew Weissman, director of vaccine research at Penn Medicine and a 2023 Nobel Prize winner for his work in pioneering mRNA technology for vaccines, and his colleagues also reported encouraging ...

PopVax’s prize-winning vaccine is built on its mRNA-encoded immunogen display approach, machine learning-enabled immunogen design feedback loop, and lipid nanoparticle (LNP) platform that boost ...

The $50 million Patch Forward Prize, part of BARDA's Project NextGen initiative, aims to accelerate the development and commercialization of microneedle patch technologies for mRNA vaccines ...

The award highlights BioNet's novel mRNA influenza vaccine candidate and its unparalleled manufacturing agility—critical for addressing emerging global health threats. The $50 million Patch Forward ...